Skip to main content
Clinical Trials/NL-OMON27238
NL-OMON27238
Completed
N/A

The PreHEART3 study

none0 sites5,150 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
none
Enrollment
5150
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

PreHEART development and validation study has been submitted

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Adults with undifferentiated chest pain.

Exclusion Criteria

  • Communication barrier (e.g. language, understanding)
  • ST\-segment elevation (electrocardiogram on scene is standard workup)
  • Any obvious etiology for the symptoms requiring direct treatment (e.g. trauma)
  • Being previously evaluated by ambulance personnel for the same complaint (already considered for participation)
  • High clinical suspicion of a life\-threating condition (e.g. sudden death survivor, hypothermia, shock, aortic dissection, hypoxia or intoxication)
  • Cognitive impairment
  • End\-stage renal disease
  • Inability or unwillingness to provide informed consent
  • Not registered with a GP (huisarts)
  • COVID suspicion

Outcomes

Primary Outcomes

Not specified

Similar Trials